CAPTRUST Financial Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,772
| Closed | -$86K | – | 2610 |
|
|
2022
Q2 | $86K | Buy |
2,772
+906
| +49% | +$28.1K | ﹤0.01% | 2319 |
|
|
2022
Q1 | $77K | Sell |
1,866
-70
| -4% | -$2.89K | ﹤0.01% | 2465 |
|
|
2021
Q4 | $84K | Buy |
1,936
+602
| +45% | +$26.1K | ﹤0.01% | 2295 |
|
|
2021
Q3 | $67K | Sell |
1,334
-132
| -9% | -$6.63K | ﹤0.01% | 2374 |
|
|
2021
Q2 | $92K | Sell |
1,466
-171
| -10% | -$10.7K | ﹤0.01% | 2092 |
|
|
2021
Q1 | $152K | Sell |
1,637
-2,218
| -58% | -$206K | ﹤0.01% | 1666 |
|
|
2020
Q4 | $345K | Buy |
3,855
+3,500
| +986% | +$313K | ﹤0.01% | 959 |
|
|
2020
Q3 | $38K | Sell |
355
-2,410
| -87% | -$258K | ﹤0.01% | 1727 |
|
|
2020
Q2 | $226K | Buy |
+2,765
| New | +$226K | ﹤0.01% | 978 |
|
|
2019
Q4 | – | Sell |
-219
| Closed | -$11K | – | 1219 |
|
|
2019
Q3 | $11K | Sell |
219
-87
| -28% | -$4.37K | ﹤0.01% | 1461 |
|
|
2019
Q2 | $15K | Buy |
306
+230
| +303% | +$11.3K | ﹤0.01% | 1368 |
|
|
2019
Q1 | $4K | Buy |
76
+34
| +81% | +$1.79K | ﹤0.01% | 1570 |
|
|
2018
Q4 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 1478 |
|